Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions
1997

Cytotoxic T-Lymphocyte Activity in Cervical Neoplasia

Sample size: 38 publication Evidence: moderate

Author Information

Author(s): HJ Bontkes, TD de Gruijl, JMM Walboomers, AJC van den Muysenberg, AW Gunther, RJ Scheper, CJLM Meijer, JA Kummer

Primary Institution: Free University Hospital

Hypothesis

Is there a role for cytotoxic T cells in (pre)malignant lesions of the cervix?

Conclusion

The study found that while there is a distinct infiltration of CD8+ T-lymphocytes in both CIN lesions and cervical carcinoma, the percentage of activated T-cells increases from CIN lesions to carcinomas.

Supporting Evidence

  • The study found that most CIN lesions had only a few activated CTLs.
  • In some carcinomas, a massive infiltration of activated CTLs was observed.
  • The presence of activated CTLs was not related to MHC class I expression on neoplastic cells.
  • Granzyme B was identified as a good marker for activated CTLs.

Takeaway

The study looked at how immune cells called T-lymphocytes behave in cervical lesions and found that more of them are activated in cancer than in pre-cancerous conditions.

Methodology

The study analyzed 14 cervical squamous cell carcinomas and 24 CIN lesions for T-cell activation markers using immunohistochemistry.

Limitations

The study did not explore the specific mechanisms behind the lack of CTL activation in some carcinomas.

Participant Demographics

Patients attending the oncological gynecological outpatient department of the Free University Hospital.

Statistical Information

P-Value

0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication